Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
ACELYRIN, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
10/13/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
10/10/2023 SC 13G FIL Ltd reports a 11.1% stake in ACELYRIN INC
10/06/2023 4 Machado Patrick (Director) has filed a Form 4 on ACELYRIN, Inc.
Txns: Acquired 14,675 shares @ $0
10/06/2023 4 Lin Shao-Lee (CEO) has filed a Form 4 on ACELYRIN, Inc.
Txns: Disposed of 1,161,747 shares @ $0
Acquired 132,236 shares @ $0
10/06/2023 4 Peloso Paul (Chief Medical Officer) has filed a Form 4 on ACELYRIN, Inc.
Txns: Acquired 39,133 shares @ $0
10/06/2023 4 Labrucherie Gil M (CFO) has filed a Form 4 on ACELYRIN, Inc.
Txns: Acquired 40,763 shares @ $0
08/21/2023 4 Labrucherie Gil M (CFO) has filed a Form 4 on ACELYRIN, Inc.
Txns: Granted 254,939 options to buy @ $26.94, valued at $6.9M
08/21/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
08/18/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/18/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/18/2023 4 Kim Mina (Chief Legal & Admin. Officer) has filed a Form 4 on ACELYRIN, Inc.
Txns: Granted 114,676 shares @ $0
08/18/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/18/2023 4 Lin Shao-Lee (CEO) has filed a Form 4 on ACELYRIN, Inc.
Txns: Granted 842,400 shares @ $0
08/14/2023 8-K Quarterly results
Docs: "ACELYRIN, INC. Reports Second Quarter 2023 Financial Results and Recent Highlights New data from Part A of Phase 2b/3 trial of izokibep in Hidradenitis Suppurativa demonstrated improvements in number of draining tunnels in two-thirds of patients as early as week 4&#59; the placebo-controlled Part B remains on track for top-line data in the third quarter 2023."
08/14/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/03/2023 3 Labrucherie Gil M (Interim CFO) has filed a Form 3 on ACELYRIN, Inc.
08/02/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Separation Agreement and Release",
"Separation Agreement and Release"
05/19/2023 SC 13G CITADEL ADVISORS LLC reports a 6.1% stake in ACELYRIN, Inc.
05/19/2023 SC 13D AI ACEL LLC reports a 5.2% stake in ACELYRIN, INC.
05/19/2023 SC 13D Westlake BioPartners Fund II, L.P. reports a 10.1% stake in ACELYRIN, INC.
05/11/2023 4 Westlake BioPartners Fund II, L.P. (10% Owner) has filed a Form 4 on ACELYRIN, Inc.
Txns: Converted 8,540,729 shares @ $0
Bought 1,250,000 shares @ $18, valued at $22.5M
Converted 4,056,795 options to buy @ $0
Converted 2,445,786 options to buy @ $0
Converted 2,038,148 options to buy @ $0
05/11/2023 4 SEIDENBERG BETH C (10% Owner) has filed a Form 4 on ACELYRIN, Inc.
Txns: Converted 8,540,729 shares @ $0
Bought 1,250,000 shares @ $18, valued at $22.5M
Bought 60,000 shares @ $18, valued at $1.1M
Converted 4,056,795 options to buy @ $0
Converted 2,445,786 options to buy @ $0
Converted 2,038,148 options to buy @ $0
Disposed of 23,243 options to buy @ $18, valued at $418.4k
Acquired 23,243 options to buy @ $18, valued at $418.4k
05/11/2023 4 Svoronos Dawn (Director) has filed a Form 4 on ACELYRIN, Inc.
Txns: Bought 15,000 shares @ $18, valued at $270k
Disposed of 155,450 options to buy @ $5.8766, valued at $913.5k
Acquired 155,450 options to buy @ $5.8766, valued at $913.5k
Disposed of 23,243 options to buy @ $18, valued at $418.4k
Acquired 23,243 options to buy @ $18, valued at $418.4k
05/11/2023 4 Machado Patrick (Director) has filed a Form 4 on ACELYRIN, Inc.
Txns: Disposed of 40,567 options to buy @ $0.7683, valued at $31.2k
Acquired 40,567 options to buy @ $0.7683, valued at $31.2k
Disposed of 86,206 options to buy @ $5.8766, valued at $506.6k
Acquired 86,206 options to buy @ $5.8766, valued at $506.6k
Disposed of 28,675 options to buy @ $5.8766, valued at $168.5k
Acquired 28,675 options to buy @ $5.8766, valued at $168.5k
Disposed of 23,243 options to buy @ $18, valued at $418.4k
Acquired 23,243 options to buy @ $18, valued at $418.4k
05/11/2023 4 Gosebruch Henry O (Director) has filed a Form 4 on ACELYRIN, Inc.
Txns: Bought 50,000 shares @ $18, valued at $900k
Disposed of 155,450 options to buy @ $7.4345, valued at $1.2M
Acquired 155,450 options to buy @ $7.4345, valued at $1.2M
05/11/2023 4 COZADD BRUCE C (Director) has filed a Form 4 on ACELYRIN, Inc.
Txns: Disposed of 183,434 options to buy @ $4.0426, valued at $741.6k
Acquired 183,434 options to buy @ $4.0426, valued at $741.6k
Disposed of 23,243 options to buy @ $18, valued at $418.4k
Acquired 23,243 options to buy @ $18, valued at $418.4k
05/11/2023 4 Becker Daniel J. (Director) has filed a Form 4 on ACELYRIN, Inc.
Txns: Bought 3,000 shares @ $18, valued at $54k
Disposed of 23,243 options to buy @ $18, valued at $418.4k
Acquired 23,243 options to buy @ $18, valued at $418.4k
05/11/2023 4 Oyston Ronald (Chief People Officer) has filed a Form 4 on ACELYRIN, Inc.
Txns: Bought 1,000 shares @ $18, valued at $18k
Bought 26 shares @ $18, valued at $468
Disposed of 165,090 options to buy @ $4.0426, valued at $667.4k
Acquired 165,090 options to buy @ $4.0426, valued at $667.4k
Disposed of 2,150 options to buy @ $4.0426, valued at $8.7k
Acquired 2,150 options to buy @ $4.0426, valued at $8.7k
Disposed of 23,412 options to buy @ $5.8766, valued at $137.6k
Acquired 23,412 options to buy @ $5.8766, valued at $137.6k
Disposed of 16,613 options to buy @ $5.8766, valued at $97.6k
Acquired 16,613 options to buy @ $5.8766, valued at $97.6k
Disposed of 131,714 options to buy @ $18, valued at $2.4M
05/11/2023 4 Kim Mina (Chief Legal & Admin. Officer) has filed a Form 4 on ACELYRIN, Inc.
Txns: Bought 5,000 shares @ $18, valued at $90k
Disposed of 362,719 options to buy @ $5.8766, valued at $2.1M
Acquired 362,719 options to buy @ $5.8766, valued at $2.1M
Disposed of 85,226 options to buy @ $18, valued at $1.5M
Acquired 85,226 options to buy @ $18, valued at $1.5M
05/11/2023 4 Gloria Melanie (COO) has filed a Form 4 on ACELYRIN, Inc.
Txns: Disposed of 330,181 options to buy @ $4.0426, valued at $1.3M
Acquired 330,181 options to buy @ $4.0426, valued at $1.3M
Disposed of 187,988 options to buy @ $5.8766, valued at $1.1M
Acquired 187,988 options to buy @ $5.8766, valued at $1.1M
Disposed of 232,436 options to buy @ $18, valued at $4.2M
Acquired 232,436 options to buy @ $18, valued at $4.2M
05/11/2023 4 Peloso Paul (Chief Medical Officer) has filed a Form 4 on ACELYRIN, Inc.
Txns: Bought 6,000 shares @ $18, valued at $108k
Disposed of 173,681 options to buy @ $0.7683, valued at $133.4k
Acquired 173,681 options to buy @ $0.7683, valued at $133.4k
Disposed of 156,500 options to buy @ $4.0426, valued at $632.7k
Acquired 156,500 options to buy @ $4.0426, valued at $632.7k
Disposed of 187,988 options to buy @ $5.8766, valued at $1.1M
Acquired 187,988 options to buy @ $5.8766, valued at $1.1M
Disposed of 154,957 options to buy @ $18, valued at $2.8M
Acquired 154,957 options to buy @ $18, valued at $2.8M
05/11/2023 4 Dier Mardi (CFO and CBO) has filed a Form 4 on ACELYRIN, Inc.
Txns: Bought 5,556 shares @ $18, valued at $100k
Bought 875 shares @ $18, valued at $15.8k
Bought 875 shares @ $18, valued at $15.8k
Disposed of 673,621 options to buy @ $5.8766, valued at $4M
Acquired 673,621 options to buy @ $5.8766, valued at $4M
Disposed of 85,226 options to buy @ $18, valued at $1.5M
Acquired 85,226 options to buy @ $18, valued at $1.5M
05/11/2023 4 Lin Shao-Lee (CEO) has filed a Form 4 on ACELYRIN, Inc.
Txns: Converted 1,161,747 shares @ $0
Disposed of 1,107,213 shares @ $0
Acquired 1,107,213 shares @ $0
Paid exercise price by delivering 337,179 shares @ $24.69, valued at $8.3M
Disposed of 677,813 shares @ $0
Acquired 677,813 shares @ $0
Disposed of 354,969 shares @ $0
Acquired 354,969 shares @ $0
Disposed of 354,969 shares @ $0
Acquired 354,969 shares @ $0
Disposed of 349,898 shares @ $0
05/11/2023 4 AyurMaya Capital Management Company, LP (Director) has filed a Form 4 on ACELYRIN, Inc.
Txns: Converted 9,334,735 shares @ $0
Converted 5,625,306 options to buy @ $0
Converted 3,709,429 options to buy @ $0
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy